A United States District Judge has dismissed a lawsuit that sought to overturn federal cannabis prohibition.
Tag Archives: DEA
RUTHERFORD COUNTY, Tenn., Feb. 13, 2018 /Weed Wire/ – Yesterday, DEA agents, detectives from the local sheriff’s office, and Smyrna, Murfreesboro, and LaVergne police raided 23 Rutherford County businesses accused of selling candy products containing cannabidiol (CBD), a non-intoxicating compound derived from the cannabis (and hemp) plant. Law enforcement claims that the products were of particular concern because they were seemingly being marketed towards minors.
WASHINGTON, D.C. Feb. 8, 2018 /Weed Wire/ – In a letter dated January 26th, Americans for Safe Access (ASA), a national nonprofit organization dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, learned that the Drug Enforcement Administration (DEA) denied their Information Quality Act (IQA) petition requesting the correction of misinformation disseminated on the DEA website on the health effects of medical cannabis, originally filed more than a year ago.
WASHINGTON, Jan. 18, 2018 /Weed Wire/ — Rep. Tulsi Gabbard (HI-02) and a bipartisan coalition of 28 Members of Congress called on the Drug Enforcement Administration (DEA) to honor Congressional legislation supporting the industrial hemp industry.
WASHINGTON, Jan. 17, 2018 /Weed Wire/ — Sen. Rand Paul, R-Ky.; Sen. Ron Wyden, D-Ore.; Rep. Jared Polis, D-Colo.; and Rep. Tom Massie, R-Ky.; defended hemp farmers and businesses, authoring an amicus brief to the 9th U.S. Circuit Court of Appeals in the Hemp Industries Assn, et. al. v. D.E.A. case.
WASHINGTON, Jan. 17, 2018 /Weed Wire/ — Rep. Jared Polis, D-Colo., defended hemp farmers and businesses, authoring a brief to the 9th U.S. Circuit Court of Appeals in the Hemp Industries Assn, et. al. v. D.E.A. case.
Cannabidiol is relatively safe and non-addictive, according to a declaration made by the World Health Organization on Dec. 13, 2017.
FRANKFORT, Dec. 13, 2017 /Weed Wire/ — Agriculture Commissioner Ryan Quarles called on Congress to remove industrial hemp from the list of controlled substances under federal law and challenged the Drug Enforcement Administration’s (DEA) position on consumable hemp-derived products in remarks delivered today at the Kentucky Department of Agriculture’s (KDA) Industrial Hemp Advisory Board meeting.
443,680 grams. That’s how much marijuana the U.S. Drug Enforcement Administration (DEA) wants federally-licensed researchers to grow for use in scientific studies in 2018.
While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.
COLUMBUS, Ohio, Oct. 31, 2017 /Weed Wire/ — Battelle announced today that it was awarded a Schedule I Researcher license by the U.S. Drug Enforcement Administration (DEA), paving the way for the leading research and development organization to conduct marijuana research with human subjects.
Washington, D.C., isn’t a large market for the cannabis industry, but it could be very influential with regards to legalization. It turns out that quite a few cannabis buyers are government employees, according to new research.
While California may grow eight times the amount of cannabis state residents can consume, the United States Drug Enforcement Administration is dimming the brilliance of the Golden State’s illegal cannabis plants.
ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.
The “gateway theory,” the theory that cannabis use leads to the use of harder drugs, has been debunked once again by academia.
Medical marijuana may be legal in Ohio and 28 other states, but the plant’s presence on the federal government’s list of most dangerous drugs has created numerous legal problems for doctors, researchers, businesses and patients.
On July 19, 2017, representatives from multiple federal agencies joined local officials in Colorado Springs to have a closed-door meeting on the effects of Colorado’s legal marijuana industry.
With members of the industrial hemp industry facing unnecessary banking hurdles, several United States Senators have joined forces to urge the Department of Justice not to use funds to punish banks that do business with them.
WASHINGTON, June 5, 2017 /Weed Wire/ – The Hemp Industries Association (HIA) and Vote Hemp launched the 8th annual Hemp History Week, to occur June 5-11, 2017, throughout the country. As event organizers advocate for full federal legalization of industrial hemp farming this Spring, Hemp History Week raises awareness about the environmental sustainability, health benefits, regenerative agriculture potential, and new technological applications of industrial hemp.
BIRMINGHAM, Al., May 31, 2017 /Weed Wire/ — Alabama candidate for U.S. Senate, Dom Gentile, today announced his support for medical cannabis, and is adding this issue to his campaign platform.
Drug Enforcement Administration acting Chief Chuck Rosenberg reiterated an Obama-era stance Thursday that “marijuana is not medicine.”
BOCA RATON, Fla., May 7, 2017 /Weed Wire/ – Maridose LLC, the Florida based company founded by former Procter & Gamble executive and advertising consultant, announced today that its’ new Maridose Marijuana Dosage Calculator is now available on the Apple APP store.
WASHINGTON, May 4, 2017 /Weed Wire/ — The Justice Department will continue to be prohibited from interfering in state medical marijuana laws under the federal spending bill passed Thursday in the Senate.
Insys Therapeutics dropped after it received disappointing news from the DEA regarding its marijuana drug Syndros.
Insys Therapeutics’ stock rose on good news — but not tremendously so.
WASHINGTON, Feb. 23, 2017 /Weed Wire/ — Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, sent a memo to Congress informing members that the Drug Enforcement Administration (DEA) has removed false information about cannabis from its website after months of public pressure.
WASHINGTON, Feb. 13, 2017 /Weed Wire/ — After months of public pressure, the Drug Enforcement Administration (DEA) has removed factually inaccurate information from its website.
Cannabis and ecommerce would complement one another like seed and soil, if only federal law would allow it.
Although the legal cannabis industry is still in its infancy, it’s already delivering tremendous results. According to tech financial guru Michael A. Robinson, the cannabis industry has been one of the fastest growing sectors in the stock market.
WASHINGTON, Jan. 18, 2017 /Weed Wire/ — Over 100,000 people have signed an Americans for Safe Access petition on Change.org demanding that the Drug Enforcement Administration (DEA) stop disseminating false information about medical cannabis immediately.
On Jan. 16, 2017, the Denver-based law firm Hoban Law Group, which represents several clients in the hemp industry, announced that it had filed a petition with the United States Court of Appeals for the Ninth Circuit to challenge a new DEA rule that would make cannabidiol illegal.
DENVER, Jan. 16, 2016 /Weed Wire/ — Hoban Law Group has filed a petition in San Francisco’s United States Court of Appeals for the Ninth Circuit to challenge what appears to be the DEA’s attempt to control an otherwise lawful substance.
As U.S. Senate hearings began on Jan. 10, 2017, for Sen. Jeff Sessions, President-elect Donald Trump’s anti-marijuana nominee for Attorney General, rumors about the Drug Enforcement Agency shutting down dispensaries were already circulating.
In a new petition from Americans for Safe Access and Change.org, over 70,000 people and counting, are calling on the Drug Enforcement Administration to stop disseminating false information about medical cannabis immediately and ensure that any future information about medical cannabis treatment reflects medically-accurate and up-to-date facts.
Most myths have at least a little bit of truth interspersed with a lot that is false. That’s the case with these three myths about marijuana stocks that some might mistakenly believe.
More are questioning the effectiveness of the government’s protracted battle against drug cartels; small steps to allow medical marijuana.
According to a survey released by the Ohio State Medical Board, only 30% of doctors in the state would be likely to recommend medical marijuana to patients with qualifying conditions.
The battle lines are heating up between the marijuana marketplace and the Drug Enforcement Agency.
Can a taxpayer who sells medical marijuana which is subject to the IRC §280E disallowance rules also be engaged in another business not subject to IRC §280E?
On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more cannabinoids are now considered a schedule I substance.
DENVER, Dec. 15, 2016 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement on the recent reports of the United States Drug Enforcement Administration’s rescheduling of all marijuana extracts, including CBD oil as Schedule I controlled substances.
DENVER, Dec. 15, 2016 /Weed Wire/ — On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids.
WASHINGTON, Dec. 5, 2016 /Weed Wire/ — Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research, filed a petition with the Department of Justice (DOJ) today demanding that the Drug Enforcement Administration (DEA) immediately update misinformation about cannabis.
“Look, I’ve been very clear about my belief that we should try to discourage substance abuse,” Obama said. “And I am not somebody who believes that legalization is a panacea. But I do believe that treating this as a public-health issue, the same way we do with cigarettes or alcohol, is the much smarter way to deal with it.”
Yesterday, Americans handed over the keys to the White House to a thin-skinned demagogue, but in eight states, at least, they also voted to legalize a way to cope with the cataclysm they wrought.
Native American-owned CannaNative LLC said on Monday it was in final talks with the Navajo Nation, the largest federally recognized tribe, to grow industrial hemp.
In some states, DEA funds for destroying marijuana plants have not amounted to money well spent, according to The Washington Post’s Wonkblog. Last year, the DEA sent $20,000 to New Hampshire for a plant eradication program, but state law enforcement agencies found one growth site with 27 plants.
Controversy is stirring in Massachusetts after state law enforcement raided the home of an 81-year-old grandmother for a single marijuana plant.
Could recreational marijuana hurt the medical marijuana community? A new report from GreenWave Advisors believes that legalized retail marijuana will disrupt the emerging medical sector.
After a series of protests in the spring—most notably a mass smoke-in at 1600 Pennsylvania Avenue—DCMJ is once again hitting the streets to advocate for making it legal to take a hit.